| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037
A quantitative assessment of rate-limiting steps in metastasis has always been challenging because of the difficulty of detecting small tumor cell populations. We have developed a highly sensitive assay for monitoring the metastatic dissemination of human tumor cells in the chick embryo and used this assay to investigate the relative efficacy of sequential stages in the metastatic cascade for two malignant human tumor cells lines, HEp3 and HT1080. This assay is based on the real-time PCR amplification of human alu sequences and exhibits a high sensitivity (25 cells/lung) with a large linear range (50–100,000 cell/lung). The assay is optimized for a high number of replicate in vivo assays (50–100 animals/assay) and can be applied in both experimental and spontaneous metastasis models. Using quantitative alu PCR, we determined that HEp3 spontaneously metastasizes very efficiently and rapidly, generating secondary growth in the lung exceeding 1–2 x 104 cells/lung in 7 days. In contrast, spontaneous HT1080 metastasis is 50–100-fold less efficient, resulting in only 200–400 cells/lung in 7 days. By taking advantage of the sensitivity and specificity of the real-time alu PCR assay we were also able to quantitatively assess multiple steps in metastasis including intravasation, arrest of tumor cells in secondary organs of the embryo, and the initial growth and expansion of the arrested tumor cells. A comparative analysis of HEp3 and HT1080 metastasis demonstrates that the relatively low-to-moderate metastatic rate of HT1080 is caused by two distinct deficiencies, an 8–10-fold lower rate of intravasation and a delayed onset of HT1080 growth expansion in the secondary organ. Thus, a very facile metastasis model system coupled with the sensitive, real-time PCR-based assay allows for the identification and quantification of rate-limiting steps in the metastatic cascade for select human tumor cell lines.
This article has been cited by other articles:
|
|
 |
|
  D. A. Nikolova, I. A. Asangani, L. D. Nelson, D. P.M. Hughes, D. R. Siwak, G. B. Mills, A. Harms, E. Buchholz, L. R. Pilz, C. Manegold, et al. Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity Cancer Res., March 15, 2009; 69(6): 2461 - 2470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Ricono, M. Huang, L. A. Barnes, S. K. Lau, S. M. Weis, D. D. Schlaepfer, S. K. Hanks, and D. A. Cheresh Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin {alpha}v{beta}5 Promotes Carcinoma Cell Invasion and Metastasis Cancer Res., February 15, 2009; 69(4): 1383 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Chen, S.-H. Liu, J.-P. Huang, J. D. Aplin, Y.-H. Wu, P.-C. Chen, C.-S. Hu, C.-C. Ko, M.-Y. Lee, and C.-Y. Chen Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats Hum. Reprod., January 1, 2009; 24(1): 154 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Conn, M. A. Madsen, B. F. Cravatt, W. Ruf, E. I. Deryugina, and J. P. Quigley Cell Surface Proteomics Identifies Molecules Functionally Linked to Tumor Cell Intravasation J. Biol. Chem., September 26, 2008; 283(39): 26518 - 26527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-A. Cho, P. Osenkowski, H. Zhao, S. Kim, M. Toth, K. Cole, A. Aboukameel, A. Saliganan, L. Schuger, R. D. Bonfil, et al. The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP J. Biol. Chem., June 20, 2008; 283(25): 17391 - 17405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Chen, M.-Y. Lee, J.-P. Huang, J. D. Aplin, Y.-H. Wu, C.-S. Hu, P.-C. Chen, H. Li, S.-M. Hwang, S.-H. Liu, et al. Trafficking of Multipotent Mesenchymal Stromal Cells from Maternal Circulation Through the Placenta Involves Vascular Endothelial Growth Factor Receptor-1 and Integrins Stem Cells, February 1, 2008; 26(2): 550 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Partridge, M. A. Madsen, V. C. Ardi, T. Papagiannakopoulos, T. A. Kupriyanova, J. P. Quigley, and E. I. Deryugina Functional Analysis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Differentially Expressed by Variants of Human HT-1080 Fibrosarcoma Exhibiting High and Low Levels of Intravasation and Metastasis J. Biol. Chem., December 7, 2007; 282(49): 35964 - 35977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-R. Lin, C.-C. Chang, L.-R. Chen, M.-H. Wu, M.-Y. Wang, I-H. Kuo, C.-Y. Chu, K.-J. Chang, P.-H. Lee, W.-J. Chen, et al. Cysteine-Rich 61 (CCN1) Enhances Chemotactic Migration, Transendothelial Cell Migration, and Intravasation by Concomitantly Up-Regulating Chemokine Receptor 1 and 2 Mol. Cancer Res., November 1, 2007; 5(11): 1111 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Stoletov, V. Montel, R. D. Lester, S. L. Gonias, and R. Klemke High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish PNAS, October 30, 2007; 104(44): 17406 - 17411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rago, D. L. Huso, F. Diehl, B. Karim, G. Liu, N. Papadopoulos, Y. Samuels, V. E. Velculescu, B. Vogelstein, K. W. Kinzler, et al. Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA Cancer Res., October 1, 2007; 67(19): 9364 - 9370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zou, J. Harrington, R. L. Rego, and D. A. Ahlquist A Novel Method to Capture Methylated Human DNA from Stool: Implications for Colorectal Cancer Screening Clin. Chem., September 1, 2007; 53(9): 1646 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Melendez-Lopez, S. Herdman, K. Hirata, M.-H. Choi, Y. Choe, C. Craik, C. R. Caffrey, E. Hansell, B. Chavez-Munguia, Y. T. Chen, et al. Use of Recombinant Entamoeba histolytica Cysteine Proteinase 1 To Identify a Potent Inhibitor of Amebic Invasion in a Human Colonic Model Eukaryot. Cell, July 1, 2007; 6(7): 1130 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-P. Sher, C.-C. Chou, R.-H. Chou, H.-M. Wu, W.-S. Wayne Chang, C.-H. Chen, P.-C. Yang, C.-W. Wu, C.-L. Yu, and K. Peck Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non-Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness Cancer Res., December 15, 2006; 66(24): 11763 - 11770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lahti, T. Teitz, and D. G. Stupack Does Integrin-Mediated Cell Death Confer Tissue Tropism in Metastasis? Cancer Res., June 15, 2006; 66(12): 5981 - 5984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Madsen, E. I. Deryugina, S. Niessen, B. F. Cravatt, and J. P. Quigley Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma Intravasation J. Biol. Chem., June 9, 2006; 281(23): 15997 - 16005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zou, J. J. Harrington, K. K. Klatt, and D. A. Ahlquist A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1115 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Podgorski and B. F. Sloane Loss of Caspase-8 in Tumor Cells: Mechanism to Overcome Integrin-Mediated Death? Mol. Interv., June 1, 2006; 6(3): 132 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Brown, M. M. Fuster, R. Li, N. Varki, C. A. Glass, and J. D. Esko A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin. Cancer Res., May 1, 2006; 12(9): 2894 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Khodavirdi, Z. Song, S. Yang, C. Zhong, S. Wang, H. Wu, C. Pritchard, P. S. Nelson, and P. Roy-Burman Increased Expression of Osteopontin Contributes to the Progression of Prostate Cancer Cancer Res., January 15, 2006; 66(2): 883 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Deryugina, A. Zijlstra, J. J. Partridge, T. A. Kupriyanova, M. A. Madsen, T. Papagiannakopoulos, and J. P. Quigley Unexpected Effect of Matrix Metalloproteinase Down-Regulation on Vascular Intravasation and Metastasis of Human Fibrosarcoma Cells Selected In vivo for High Rates of Dissemination Cancer Res., December 1, 2005; 65(23): 10959 - 10969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Blancafort, E. I. Chen, B. Gonzalez, S. Bergquist, A. Zijlstra, D. Guthy, A. Brachat, R. H. Brakenhoff, J. P. Quigley, D. Erdmann, et al. Genetic reprogramming of tumor cells by zinc finger transcription factors PNAS, August 16, 2005; 102(33): 11716 - 11721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, A. S. Lalani, T. C. Harding, M. Gonzalez, W.-W. Wu, B. Luan, G. H. Tu, K. Koprivnikar, M. J. VanRoey, Y. He, et al. Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy Receptor Cancer Res., August 1, 2005; 65(15): 6901 - 6909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goodison, J. Yuan, D. Sloan, R. Kim, C. Li, N. C. Popescu, and V. Urquidi The RhoGAP Protein DLC-1 Functions as a Metastasis Suppressor in Breast Cancer Cells Cancer Res., July 15, 2005; 65(14): 6042 - 6053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Aguirre-Ghiso, L. Ossowski, and S. K. Rosenbaum Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic Growth Cancer Res., October 15, 2004; 64(20): 7336 - 7345. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
